Financhill
Sell
28

QTRX Quote, Financials, Valuation and Earnings

Last price:
$7.12
Seasonality move :
14.4%
Day range:
$7.07 - $7.42
52-week range:
$6.80 - $27.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.10x
P/B ratio:
0.83x
Volume:
565.4K
Avg. volume:
702.2K
1-year change:
-72.58%
Market cap:
$280.5M
Revenue:
$121.1M
EPS (TTM):
-$0.93

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
QTRX
Quanterix
$34.9M -- 12.51% -- $17.00
AKYA
Akoya Biosciences
$21.3M -$0.16 8.83% -56.77% $3.48
HOLX
Hologic
$1B $1.02 -1.37% 41.32% $79.28
NUWE
Nuwellis
$2.5M -- 34.63% -- $13.00
TMDX
TransMedics Group
$109.5M $0.15 27.41% -31.06% $102.86
VREX
Varex Imaging
$202.2M $0.04 0.27% 358.33% $21.20
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
QTRX
Quanterix
$7.28 $17.00 $280.5M -- $0.00 0% 2.10x
AKYA
Akoya Biosciences
$1.56 $3.48 $77.3M -- $0.00 0% 0.89x
HOLX
Hologic
$61.82 $79.28 $13.9B 19.50x $0.00 0% 3.60x
NUWE
Nuwellis
$1.16 $13.00 $5.1M -- $0.00 0% 0.21x
TMDX
TransMedics Group
$67.75 $102.86 $2.3B 67.08x $0.00 0% 5.40x
VREX
Varex Imaging
$12.82 $21.20 $528.6M 17.58x $0.00 0% 0.64x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
QTRX
Quanterix
-- 1.645 -- 8.90x
AKYA
Akoya Biosciences
84.77% -0.175 56.35% 1.74x
HOLX
Hologic
34.61% 0.777 15.53% 2.60x
NUWE
Nuwellis
-- 2.080 -- 2.67x
TMDX
TransMedics Group
69.02% 2.445 24.3% 7.25x
VREX
Varex Imaging
51.21% 1.717 92.11% 2.33x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
QTRX
Quanterix
$19.8M -$11.7M -10.38% -10.38% -33.18% -$6.6M
AKYA
Akoya Biosciences
$11.7M -$7.4M -52.65% -157.22% -41.8% -$9.7M
HOLX
Hologic
$580.5M $233.7M 10.04% 15.28% 27.21% $142.3M
NUWE
Nuwellis
$1.4M -$2.4M -800.59% -800.59% -63.18% -$1.5M
TMDX
TransMedics Group
$72M $8.6M 5.12% 19.17% 8.68% $6.1M
VREX
Varex Imaging
$68.5M $11.2M -4.56% -8.27% 4.81% $5.3M

Quanterix vs. Competitors

  • Which has Higher Returns QTRX or AKYA?

    Akoya Biosciences has a net margin of -23.59% compared to Quanterix's net margin of -55.99%. Quanterix's return on equity of -10.38% beat Akoya Biosciences's return on equity of -157.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    55.78% -$0.22 $338.9M
    AKYA
    Akoya Biosciences
    62.32% -$0.21 $89.5M
  • What do Analysts Say About QTRX or AKYA?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 171.29%. On the other hand Akoya Biosciences has an analysts' consensus of $3.48 which suggests that it could grow by 123.08%. Given that Quanterix has higher upside potential than Akoya Biosciences, analysts believe Quanterix is more attractive than Akoya Biosciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    AKYA
    Akoya Biosciences
    1 7 0
  • Is QTRX or AKYA More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Akoya Biosciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock QTRX or AKYA?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Akoya Biosciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Akoya Biosciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or AKYA?

    Quanterix quarterly revenues are $35.4M, which are larger than Akoya Biosciences quarterly revenues of $18.8M. Quanterix's net income of -$8.4M is higher than Akoya Biosciences's net income of -$10.5M. Notably, Quanterix's price-to-earnings ratio is -- while Akoya Biosciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.10x versus 0.89x for Akoya Biosciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.10x -- $35.4M -$8.4M
    AKYA
    Akoya Biosciences
    0.89x -- $18.8M -$10.5M
  • Which has Higher Returns QTRX or HOLX?

    Hologic has a net margin of -23.59% compared to Quanterix's net margin of 19.67%. Quanterix's return on equity of -10.38% beat Hologic's return on equity of 15.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    55.78% -$0.22 $338.9M
    HOLX
    Hologic
    56.81% $0.87 $7.3B
  • What do Analysts Say About QTRX or HOLX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 171.29%. On the other hand Hologic has an analysts' consensus of $79.28 which suggests that it could grow by 28.25%. Given that Quanterix has higher upside potential than Hologic, analysts believe Quanterix is more attractive than Hologic.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    HOLX
    Hologic
    3 14 0
  • Is QTRX or HOLX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Hologic has a beta of 0.971, suggesting its less volatile than the S&P 500 by 2.862%.

  • Which is a Better Dividend Stock QTRX or HOLX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or HOLX?

    Quanterix quarterly revenues are $35.4M, which are smaller than Hologic quarterly revenues of $1B. Quanterix's net income of -$8.4M is lower than Hologic's net income of $201M. Notably, Quanterix's price-to-earnings ratio is -- while Hologic's PE ratio is 19.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.10x versus 3.60x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.10x -- $35.4M -$8.4M
    HOLX
    Hologic
    3.60x 19.50x $1B $201M
  • Which has Higher Returns QTRX or NUWE?

    Nuwellis has a net margin of -23.59% compared to Quanterix's net margin of -63.22%. Quanterix's return on equity of -10.38% beat Nuwellis's return on equity of -800.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    55.78% -$0.22 $338.9M
    NUWE
    Nuwellis
    58.36% -$0.44 $6.5M
  • What do Analysts Say About QTRX or NUWE?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 171.29%. On the other hand Nuwellis has an analysts' consensus of $13.00 which suggests that it could grow by 1020.69%. Given that Nuwellis has higher upside potential than Quanterix, analysts believe Nuwellis is more attractive than Quanterix.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    NUWE
    Nuwellis
    0 1 0
  • Is QTRX or NUWE More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Nuwellis has a beta of 0.359, suggesting its less volatile than the S&P 500 by 64.091%.

  • Which is a Better Dividend Stock QTRX or NUWE?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Nuwellis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or NUWE?

    Quanterix quarterly revenues are $35.4M, which are larger than Nuwellis quarterly revenues of $2.3M. Quanterix's net income of -$8.4M is lower than Nuwellis's net income of -$1.5M. Notably, Quanterix's price-to-earnings ratio is -- while Nuwellis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.10x versus 0.21x for Nuwellis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.10x -- $35.4M -$8.4M
    NUWE
    Nuwellis
    0.21x -- $2.3M -$1.5M
  • Which has Higher Returns QTRX or TMDX?

    TransMedics Group has a net margin of -23.59% compared to Quanterix's net margin of 5.64%. Quanterix's return on equity of -10.38% beat TransMedics Group's return on equity of 19.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    55.78% -$0.22 $338.9M
    TMDX
    TransMedics Group
    59.21% $0.19 $737.9M
  • What do Analysts Say About QTRX or TMDX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 171.29%. On the other hand TransMedics Group has an analysts' consensus of $102.86 which suggests that it could grow by 51.82%. Given that Quanterix has higher upside potential than TransMedics Group, analysts believe Quanterix is more attractive than TransMedics Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    TMDX
    TransMedics Group
    5 3 0
  • Is QTRX or TMDX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison TransMedics Group has a beta of 2.121, suggesting its more volatile than the S&P 500 by 112.09%.

  • Which is a Better Dividend Stock QTRX or TMDX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TransMedics Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. TransMedics Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or TMDX?

    Quanterix quarterly revenues are $35.4M, which are smaller than TransMedics Group quarterly revenues of $121.6M. Quanterix's net income of -$8.4M is lower than TransMedics Group's net income of $6.9M. Notably, Quanterix's price-to-earnings ratio is -- while TransMedics Group's PE ratio is 67.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.10x versus 5.40x for TransMedics Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.10x -- $35.4M -$8.4M
    TMDX
    TransMedics Group
    5.40x 67.08x $121.6M $6.9M
  • Which has Higher Returns QTRX or VREX?

    Varex Imaging has a net margin of -23.59% compared to Quanterix's net margin of -0.15%. Quanterix's return on equity of -10.38% beat Varex Imaging's return on equity of -8.27%.

    Company Gross Margin Earnings Per Share Invested Capital
    QTRX
    Quanterix
    55.78% -$0.22 $338.9M
    VREX
    Varex Imaging
    34.28% -$0.01 $1.1B
  • What do Analysts Say About QTRX or VREX?

    Quanterix has a consensus price target of $17.00, signalling upside risk potential of 171.29%. On the other hand Varex Imaging has an analysts' consensus of $21.20 which suggests that it could grow by 65.37%. Given that Quanterix has higher upside potential than Varex Imaging, analysts believe Quanterix is more attractive than Varex Imaging.

    Company Buy Ratings Hold Ratings Sell Ratings
    QTRX
    Quanterix
    2 1 0
    VREX
    Varex Imaging
    3 1 0
  • Is QTRX or VREX More Risky?

    Quanterix has a beta of 1.336, which suggesting that the stock is 33.57% more volatile than S&P 500. In comparison Varex Imaging has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.729%.

  • Which is a Better Dividend Stock QTRX or VREX?

    Quanterix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Quanterix pays -- of its earnings as a dividend. Varex Imaging pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QTRX or VREX?

    Quanterix quarterly revenues are $35.4M, which are smaller than Varex Imaging quarterly revenues of $199.8M. Quanterix's net income of -$8.4M is lower than Varex Imaging's net income of -$300K. Notably, Quanterix's price-to-earnings ratio is -- while Varex Imaging's PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Quanterix is 2.10x versus 0.64x for Varex Imaging. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QTRX
    Quanterix
    2.10x -- $35.4M -$8.4M
    VREX
    Varex Imaging
    0.64x 17.58x $199.8M -$300K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock